Treurniet, Kilian M.
,
LeCouffe, Natalie E.
Kappelhof, Manon
Emmer, Bart J.
van Es, Adriaan C. G. M.
Boiten, Jelis
Lycklama, Geert J.
Keizer, Koos
Yo, Lonneke S. F.
Lingsma, Hester F.
van Zwam, Wim H.
de Ridder, Inger
van Oostenbrugge, Robert J.
van der Lugt, Aad
Dippel, Diederik W. J.
Coutinho, Jonathan M.
Roos, Yvo B. W. E. M.
Majoie, Charles B. L. M. http://orcid.org/0000-0002-7600-9568
Funding for this research was provided by:
Hartstichting
Hersenstichting
Stryker
Article History
Received: 3 September 2020
Accepted: 20 January 2021
First Online: 15 February 2021
Ethics approval and consent to participate
: In the Netherlands, the medical ethical committee of the Erasmus University Medical Center in Rotterdam approved this study in 2017 (MEC number: 2017-368). In France, the study was approved by the Comité de Protection des Personnes, Ile de France IV (ID-RCB: 2018-A00764-51). In Belgium, the study was approved by the Comité d’Ethique Medicale, CHC, Liège, Belgium (study number: 19/20/987). Written informed consent (deferred) for trial participation and their anonymized information to be published will be obtained from patient(s) or their legal representatives.
: Not applicable.
: WZ reports that Maastricht University Medical Center received compensation from Stryker® and Cerenovus® for consultations by WvZ;YR reports that he is a shareholder of Nico.labJMC reports that Amsterdam UMC received research support from Medtronic.CM reports that Amsterdam UMC received research grants form CVON/Dutch Heart Foundation, European Commission, TWIN Foundation and Stryker®; he is a shareholder of Nico.lab.DD and AvdL report that Erasmus MC received research grants from Dutch Heart Foundation, Dutch Brain Foundation, AngioCare BV, Covidien/EV3®, MEDAC Gmbh/LAMEPRO, Penumbra Inc., Stryker, and Top Medical/Concentric, The Netherlands Organization for Health Research and Development, Health Holland Top Sector Life Sciences & Health, Stryker, Thrombolytic Science, LLC, and Cerenovus.All other authors declare that they have no competing interests.